Insulet (PODD) Net Margin (2010 - 2026)
Insulet posted quarterly Net Margin of 11.96% for Q1 2026, up 572.0% year-on-year from 1.78% in Q1 2025, and down 7.82% on a QoQ basis from 12.98% in Q4 2025.
Insulet (PODD) has 16 years of Net Margin data on file, last reported at 11.96% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 572.0% year-over-year to 11.96%; the trailing twelve-month figure through Mar 2026 stood at 10.44% (down 785.0% YoY), and the FY2025 full-year result was 9.12%, down 1107.0% from the prior year.
- Net Margin for Q1 2026 stood at 11.96%, down from 12.98% in the prior quarter.
- Across five years, Net Margin topped out at 38.61% in Q2 2024 and bottomed at 11.69% in Q2 2022.
- The 5-year median for Net Margin is 11.66% (2024), against an average of 10.4%.
- The widest annual swing landed in 2024, when Net Margin surged 3172 bps; it then plunged 3514 bps in 2025.
- A 5-year view of Net Margin shows it stood at 4.6% in 2022, then soared by 341 bps to 20.28% in 2023, then dropped by 17 bps to 16.85% in 2024, then dropped by 23 bps to 12.98% in 2025, then slipped by 8 bps to 11.96% in 2026.
- The last three Net Margin figures came in at 11.96% (Q1 2026), 12.98% (Q4 2025), and 12.4% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 11.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.96% |
| Dec 31, 2025 | 12.98% |
| Sep 30, 2025 | 12.40% |
| Jun 30, 2025 | 3.47% |
| Mar 31, 2025 | 6.24% |
| Dec 31, 2024 | 16.85% |
| Sep 30, 2024 | 14.25% |
| Jun 30, 2024 | 38.61% |
| Mar 31, 2024 | 11.66% |
| Dec 31, 2023 | 20.28% |
| Sep 30, 2023 | 11.99% |
| Jun 30, 2023 | 6.89% |
| Mar 31, 2023 | 6.65% |
| Dec 31, 2022 | 4.60% |
| Sep 30, 2022 | -1.53% |
| Jun 30, 2022 | -11.69% |
| Mar 31, 2022 | 11.26% |
| Dec 31, 2021 | 8.93% |
| Sep 30, 2021 | 4.57% |
| Jun 30, 2021 | -9.62% |
| Dec 31, 2020 | -6.95% |
| Sep 30, 2020 | 4.96% |
| Jun 30, 2020 | 6.36% |
| Mar 31, 2020 | -1.06% |
| Dec 31, 2019 | 2.39% |
| Sep 30, 2019 | 0.42% |
| Jun 30, 2019 | 0.79% |
| Mar 31, 2019 | 2.76% |
| Dec 31, 2018 | 6.00% |
| Sep 30, 2018 | 1.10% |
| Jun 30, 2018 | -1.36% |
| Mar 31, 2018 | -5.29% |
| Dec 31, 2016 | 0.03% |
| Sep 30, 2016 | -0.07% |
| Jun 30, 2016 | 0.18% |
| Mar 31, 2016 | -2.21% |
| Dec 31, 2015 | -13.63% |
| Sep 30, 2015 | -1.32% |
| Jun 30, 2015 | 3.03% |
| Mar 31, 2015 | -2.89% |
| Dec 31, 2014 | -2.54% |
| Sep 30, 2014 | -14.46% |
| Jun 30, 2014 | -40.42% |
| Mar 31, 2014 | -8.88% |
| Dec 31, 2013 | -3.65% |
| Sep 30, 2013 | -34.84% |
| Jun 30, 2013 | -17.50% |
| Mar 31, 2013 | -18.59% |
| Dec 31, 2012 | -17.63% |
| Sep 30, 2012 | -22.68% |
| Jun 30, 2012 | -28.36% |
| Mar 31, 2012 | -30.95% |
| Dec 31, 2011 | -30.38% |
| Sep 30, 2011 | -30.41% |
| Jun 30, 2011 | -25.10% |
| Mar 31, 2011 | -34.85% |
| Dec 31, 2010 | -75.12% |
| Sep 30, 2010 | -47.53% |
| Jun 30, 2010 | -59.78% |